PF-08049820 for Eczema Treatment
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Recruiting
Phase 2
Interventional Study
Atopic Dermatitis
Eczema, Atopic
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 64
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 165 (estimated)
- Sponsor
- Pfizer · Industry
Who this trial is looking for
This trial is looking for adults aged 18 to 64 with moderate to severe eczema who have not found a suitable treatment. Participants will take either the study medicine PF-08049820 or a placebo for 12 weeks and visit the clinic several times to check their health and skin condition.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 to 64 years old
- I have been diagnosed with eczema for at least 6 months
- I have moderate to severe eczema
- I do not have a suitable prescribed medicine for eczema
- I have a body weight greater than 48 kg
You may not be able to join if
- I have an infection that requires treatment
- I have other skin conditions besides eczema
- I have severe uncontrolled asthma
- I have used a tanning booth or phototherapy for eczema more than twice a week in the last 4 weeks
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have severe itching and rashes on the skin.
The study is seeking participants who:
1. Are 18 to 64 years of age;
2. Were confirmed to have AD at least 6 months ago;
3. Do not have a suit…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Participants must meet the following criteria:
1. Are 18 to 64 years of age
2. Have clinical diagnosis of AD for at least 6 months prior to Day 1 and have diagnosis of AD confirmed by photographs
3. Have moderate to severe AD as defined by the following at screening and baselin…
Contacts